Allspring Global Investments
GOSS icon

Allspring Global Investments’s Gossamer Bio GOSS Stock Holding History

Allspring Global Investments’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,037
Closed -$2.57K – 2743
2023
Q1 		$2.57K Sell
2,037
-8,359
-80% -$16K ﹤0.01% 2692
2022
Q4 		$22.6K Sell
10,396
-26,843
-72% -$221K ﹤0.01% 2562
2022
Q3 		$446K Buy
37,239
+10,129
+37% +$126K ﹤0.01% 1608
2022
Q2 		$226K Buy
27,110
+10,908
+67% +$84.5K ﹤0.01% 1778
2022
Q1 		$140K Buy
16,202
+1,584
+11% +$15.3K ﹤0.01% 2676
2021
Q4 		$165K Buy
+14,618
New +$174K ﹤0.01% 2671

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Allspring Global Investments's GOSS Position: Q2 2023 in Review

Allspring Global Investments sold out of Gossamer Bio (GOSS) in Q2 2023, closing a stake of 2,037 shares — an estimated $2.57K sold.

Allspring Global Investments first reported a position in GOSS in Q4 2021 and held it in 6 quarters. The position peaked at $446K in Q3 2022. 99 funds tracked by Wall St. Rank hold GOSS as of Q2 2023.

  • Allspring Global Investments reported no remaining Gossamer Bio position as of Q2 2023 after selling out during the quarter.
  • Allspring Global Investments sold 2,037 Gossamer Bio shares in Q2 2023, an estimated $2.57K.
  • Allspring Global Investments first reported a position in Gossamer Bio in Q4 2021 and held it in 6 quarters.
  • Allspring Global Investments's Gossamer Bio position peaked at $446K in Q3 2022.
  • 99 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2023.

Based on Allspring Global Investments's 13F filing for Q2 2023, filed 18 Jul 2023.